In recent years, there has been a shift towards empowering patients to take greater responsibility for their own health and well-being. This paradigm shift has given rise to the concept of E-Health, which leverages digital tools to help patients maintain prolonged periods of remission. The benefits of E-Health extend not only to patients but also to healthcare providers, hospitals, and society as a whole. It has the potential to reduce the reliance on heavy medications, emergency hospital admissions, costly surgeries, and other expensive treatments.
Both patients and clinicians require the necessary tools to manage IBD, whether it's Crohn's Disease or Ulcerative Colitis. A personalized digital therapy plan tailored to individual needs can make a world of difference.
The CalproSmart self-test is a valuable tool in the arsenal of IBD patients. This at-home test enables individuals to monitor inflammation levels in their bowel independently. It's a straightforward process, involving a step-by-step guide and capturing an image of the lateral flow test cassette using a mobile phone application. An E-Health application interprets the results and displays the inflammation levels both quantitatively (in mg/kg), and with a traffic light indicator for patients to understand easily.
Moreover, as clinicians you can receive direct alerts and can then determine which patient may require specific interventions or care. This proactive approach means that flare-ups can be managed early, swiftly, and effectively, often stopping symptoms in the beginning before they escalate into more serious ones.
Ankersen DV et al., E-Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need. Intern Med J. 2021.
Burisch J et al., Telemonitoring and self-care in patients with IBD. In: RK Cross and AR Watson, eds. Telemanagement of Inflammatory Bowel Disease. Springer US; 2015.
De Jong MJ, et al., Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017.
De Jong MJ, et al., Costeffectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial. Clin Gastroenterol Hepatol. 2020.
Pang L, et al., Role of Telemedicinein Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Med Internet Res. 2022.